Literature DB >> 31928573

Esophago-Gastric Cancer after One Anastomosis Gastric Bypass (OAGB).

Mira Runkel, Norbert Runkel.   

Abstract

One Anastomosis Gastric Bypass (OAGB) is a bariatric technique that combines a long tube-like gastric conduit with a wide end-to-side gastro-jejunostomy. It is a non-complex operation with a low frequency of intestinal obstructions and an excellent long-term weight loss, however, there is a fear of esophagogastric cancer. This narrative review explores the risk of cancer development after OAGB. Five gastric cancers were published after loop gastric bypass (an early version of OAGB, n=4) and after modern OAGB (n=1), four of which occurred in the remnant stomach and one in the gastric stump. Jejuno-gastric reflux is normal after OAGB, but there is little or no evidence to suggest bile-induced malignant degeneration in the stomach. On the contrary, gastro-esophageal reflux is a clear cause of metaplasia and AEG, although gastro-esophageal reflux is rare after OAGB with only two cases of AEG in the literature. Postoperative gastroscopic surveillance should be considered in patients with gastro-esophageal reflux and/or hiatal hernia. When reflux becomes symptomatic, diversion of the OAGB into a Roux-en-Y construction should be recommended. Celsius.

Entities:  

Keywords:  MGB; OAGB; OneAnastomosisGastricBypass; bariatric; bilereflux; esophagealcancer; gastriccancer

Year:  2019        PMID: 31928573     DOI: 10.21614/chirurgia.114.6.686

Source DB:  PubMed          Journal:  Chirurgia (Bucur)        ISSN: 1221-9118


  2 in total

1.  Routine Use of Esophago-gastro-duodenoscopy (EGD) in Bariatric Surgery-an International Survey of Our Current Practice.

Authors:  Sharmaine Yen Ling Quake; Ghazaleh Mohammadi-Zaniani; Aya Musbahi; Oliver Old; Michael Courtney; Peter Small
Journal:  Obes Surg       Date:  2022-09-03       Impact factor: 3.479

2.  Linear or circular: Anastomotic ulcer after gastric bypass surgery.

Authors:  Aline Schäfer; Philipp Gehwolf; Katrin Kienzl-Wagner; Fergül Cakar-Beck; Heinz Wykypiel
Journal:  Surg Endosc       Date:  2021-06-18       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.